BioMonitor Master Study (BioMonitor)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01725568
Recruitment Status : Completed
First Posted : November 14, 2012
Last Update Posted : November 20, 2014
Information provided by (Responsible Party):
Biotronik SE & Co. KG

November 6, 2012
November 14, 2012
November 20, 2014
November 2012
October 2014   (Final data collection date for primary outcome measure)
  • SADE free-rate [ Time Frame: at 3 month follow-up ]
    SADE free-rate > 90% at 3 month follow-up
  • Rate of appropriate QRS detection [ Time Frame: at 6 week follow-up ]
    Rate of appropriate QRS detection > 90% (based on comparison with Holter ECG recording)
Same as current
Complete list of historical versions of study NCT01725568 on Archive Site
Not Provided
Not Provided
  • Sensitivity and Positive Predictive of episode detection [ Time Frame: 1 year ]
    Sensitivity and Positive Predictive Value of each automatically detected cardiac arrhythmia that was stored as subcutaneous electrocardiogram by the BioMonitor (6 week, 3 and 12 month follow-up data)
  • Adverse events [ Time Frame: 1 year ]
Same as current
BioMonitor Master Study
Master Study of the Implantable Cardiac Monitor "BioMonitor"
The BioMonitor is an implantable cardiac monitor used to automatically detect and record episodes of arrhythmia in patients with bradycardia, tachycardia, asystole and atrial fibrillation. The study will be conducted to support regulatory approvals outside of Europe. This BioMonitor Master study is designed to investigate the clinical efficacy and safety of the BioMonitor.
Not Provided
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients with standard ICM indication who are referred to the hospital
Device: BioMonitor
Implantable cardiac monitor
Implantable cardiac monitor diagnostics
Patients has standard indication for implantable cardiac monitor diagnostic.
Intervention: Device: BioMonitor
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
October 2014
October 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Suspected cardiac arrhythmia OR Previous AF diagnosis OR AF diagnosis before or after ablation procedure OR Stroke of unknown origin.

Exclusion Criteria:

  • Implanted ICD or cardiac pacemaker
  • Allergy to patch electrodes
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Biotronik SE & Co. KG
Biotronik SE & Co. KG
Not Provided
Principal Investigator: Dietmar Baensch, Professor University of Rostock, Germany
Biotronik SE & Co. KG
November 2014